Dizal’s ZEGFROVY® (Sunvozertinib) New Drug Application Accepted and Granted Priority Review by China National Medical Products Administration for First-Line Treatment of EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancerby krapalmMay 27, 2026PR Newswire
Kingsoft Cloud Announces Unaudited First Quarter 2026 Financial Resultsby krapalmMay 27, 2026PR Newswire
Club Med celebrates strong performance in 2025 and primed for 2026 expansionby krapalmMay 27, 2026PR Newswire
Tencent Announces Three Initiatives to Make Inbound Payments for International Visitors Easier Than Ever During APEC 2026by krapalmMay 27, 2026PR Newswire
Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBVby krapalmMay 27, 2026PR Newswire
iQIYI’s AI Platform Nadou Pro Surpasses 10,000 Creators, Unveils Advanced Feature Updates and Global Expansionby krapalmMay 27, 2026PR Newswire
Fosun International Recognized on Fortune’s 2026 “Most Admired Chinese Companies” Listby krapalmMay 27, 2026PR Newswire
TXOne Networks’ Nasser Zayour on Why Execution, Not Visibility, Will Define the Next Phase of OT Securityby krapalmMay 27, 2026PR Newswire
ViaBTC เปิดตัวแคมเปญใหญ่ “Proof of Decade” ฉลองครบรอบ 10 ปี ตอกย้ำความสำเร็จในเวทีโลกby krapalmMay 27, 2026PR Newswire
ViaBTC Launches “Proof of Decade” Campaign to Celebrate 10th Anniversaryby krapalmMay 27, 2026PR Newswire
European Travel Media and Influencers’ Hainan Tour kicks off in Haikouby krapalmMay 27, 2026PR Newswire
